Diverse biological mechanisms drive resistance to Lorlatinib in ALK-rearranged Lung Cancer
Gonzalo Recondo,Laura Mezquita,David Planchard,Anas Gazzah,Francesco Facchinetti,Ludovic Bigot,Ahsan Z. Rizvi,Jean-Paul Thiery,Jean-Yves Scoazec, Rosa L. Frias,Tony Sourisseau, Linda Mahjoubi, Justine Galissant, Aurelie Abou-Lovergne,Gilles Vassal,Rastislav Bahleda,Antoine Hollebecque,Claudio Nicotra,Maud Ngocamus,Stefan Michiels,Ludovic Lacroix,Catherine Richon,Nathalie Auger,Thierry De Baere,Frederic Deschamps, Eric Salary,Ken A. Olaussen,Eric Angevin,Alexander Eggermont,Fabrice Andre,Christophe Massard,Jean-Charles Soria,Benjamin Besse,Luc Friboulet CANCER RESEARCH(2019)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)